Biblio Discovery — Demo Discovery Service

24 hasil untuk "Samra Turajlic"

Menampilkan 1–20 · 0,42 detik · RSS

  1. Artikel Jurnal

    Tumour mutational burden: primary versus metastatic tissue creates systematic bias

    Desiree Schnidrig; Samra Turajlic; Kevin Litchfield

    Immuno-Oncology and Technology, Vol. 4 · 2019 · Inggris · DOAJ Scopus

    Tumour mutational burden (TMB) has emerged as a reproducible biomarker to predict immunotherapy response across multiple cancer types. However, a key aspect of TMB measurement that is often overlooked is the source of tissue sample used, which creates a potential for systematic bias. The…

  2. Artikel Jurnal

    Immune-checkpoint inhibitors in melanoma and kidney cancer: from sequencing to rational selection

    Michael Flynn; Lisa Pickering; James Larkin dkk.

    Therapeutic Advances in Medical Oncology, Vol. 10 · 2018 · Inggris · DOAJ Scopus

    Immune-checkpoint inhibitors (ICPIs), including antibodies against cytotoxic T-lymphocyte associated antigen 4 and programmed cell death protein 1, have been shown to induce durable complete responses in a proportion of patients in the first-line and refractory setting in advanced melanoma and…

  3. Artikel Jurnal

    Targeted therapy and immunotherapy in advanced melanoma: an evolving paradigm

    Muhammad Khattak; Rosalie Fisher; Samra Turajlic dkk.

    Therapeutic Advances in Medical Oncology, Vol. 5 · 2013 · Inggris · DOAJ Scopus

    Metastatic melanoma is one of the most challenging malignancies to treat and often has a poor outcome. Until recently, systemic treatment options were limited, with poor response rates and no survival advantage. However, the treatment of metastatic melanoma has been revolutionized by developments…

  4. Artikel Jurnal

    Clinical and immunologic implications of COVID-19 in patients with melanoma and renal cell carcinoma receiving immune checkpoint inhibitors

    John Haanen; Samra Turajlic; Igor Puzanov dkk.

    Journal for ImmunoTherapy of Cancer, Vol. 9 No. 7 · 2021 · Inggris · DOAJ Scopus

    The clinical and immunologic implications of the SARS-CoV-2 pandemic for patients with cancer receiving systemic anticancer therapy have introduced a multitude of clinical challenges and academic controversies. This review summarizes the current evidence, discussion points, and recommendations…

  5. Artikel Jurnal

    Chronic interferon signaling at baseline is associated with acquired resistance to immunotherapy in metastatic melanoma

    Donagh Egan; Ben Shum; Rabia Fidan dkk.

    Cell Reports Medicine, Vol. 7 No. 8 · 2026 · Inggris · DOAJ Scopus

    Summary: Interferons can trigger robust anti-tumor responses following immune checkpoint blockade (ICB). However, chronic interferon signaling can also reshape tumor cell phenotypes, selecting for immune evasion mechanisms that drive resistance. In a cohort of 108 metastatic melanoma samples…

  6. Artikel Jurnal

    Five-year review of corticosteroid duration and complications in the management of immune checkpoint inhibitor-related diarrhoea and colitis in advanced melanoma

    Lavinia Spain; James M Larkin; Samra Turajlic dkk.

    ESMO Open, Vol. 5 No. 4 · 2020 · Inggris · DOAJ Scopus

    Background Immune-related diarrhoea/colitis (ir-D/C) is a common adverse event of immune checkpoint inhibitor (ICI) therapy. Guidelines recommend corticosteroid (CS) treatment; however, the average treatment duration for ir-D/C remains poorly defined.Methods All advanced melanoma patients treated…

  7. Artikel Jurnal

    Generation of TWO iPSC lines (CRICKi009-A; CRICKi010-A) from patients with type 1 von Hippel-Lindau (VHL) and histopathologically confirmed renal cell carcinoma (RCC)

    Liani G. Devito; Eugénie S. Lim; Samuel M. O’Toole dkk.

    Stem Cell Research, Vol. 81 · 2024 · Inggris · DOAJ Scopus

    VHL disease is an inherited and autosomal dominant disorder affecting 1 in 36,0000 individuals worldwide. It is caused by von Hippel-Lindau (VHL) gene mutations and can affect both genders and all ethnic backgrounds (Nordstrom-O’Brien et al., 2009; Maher, 2004). Here, we generated and characterised…

  8. Artikel Jurnal Teks lengkap

    The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours

    Holger Moch; Mahul B. Amin; Daniel Maurice Berney dkk.

    European Urology · 2022 · Inggris · OpenAlex Scopus

    The fifth edition of the World Health Organization (WHO) classification of urogenital tumours (WHO "Blue Book"), published in 2022, contains significant revisions. This review summarises the most relevant changes for renal, penile, and testicular tumours. In keeping with other volumes in the fifth…

  9. Artikel Jurnal

    A protocol for representative sampling of solid tumors to improve the accuracy of sequencing results

    Lisa L. Gallegos; Ashley Gilchrist; Lavinia Spain dkk.

    STAR Protocols, Vol. 2 No. 3 · 2021 · Inggris · DOAJ Scopus

    Summary: Owing to spatial segregation of tumor subclones, solid tumor sampling using formalin-fixed, paraffin-embedded blocks is often inadequate to represent the genomic heterogeneity of solid tumors. We present an approach, representative sampling, to dissect and homogenize leftover residual…

  10. Artikel Jurnal

    Oral beclomethasone dipropionate is an effective treatment for immune checkpoint inhibitor induced colitis

    Hajir Ibraheim; Sophie Papa; Nick Powell dkk.

    Journal for ImmunoTherapy of Cancer, Vol. 10 No. 9 · 2022 · Inggris · DOAJ Scopus

    Introduction Systemic corticosteroids are the mainstay of treatment for immune checkpoint inhibitor induced (CPI) colitis but are associated with complications including life-threatening infection. The topically acting oral corticosteroid beclomethasone dipropionate (BD) is an effective treatment…

  11. Artikel Jurnal

    Therapeutic inhibition of monocyte recruitment prevents checkpoint inhibitor-induced hepatitis

    Nick Powell; Mark R Thursz; Kevin J Woollard dkk.

    Journal for ImmunoTherapy of Cancer, Vol. 12 No. 4 · 2024 · Inggris · DOAJ Scopus

    Background Checkpoint inhibitor-induced hepatitis (CPI-hepatitis) is an emerging problem with the widening use of CPIs in cancer immunotherapy. Here, we developed a mouse model to characterize the mechanism of CPI-hepatitis and to therapeutically target key pathways driving this pathology.Methods…

  12. Artikel Jurnal

    The spectrum of cardiovascular complications related to immune-checkpoint inhibitor treatment

    Maria Sol Andres; Sivatharshini Ramalingam; Stuart D. Rosen dkk.

    Cardio-Oncology, Vol. 8 No. 1 · 2022 · Inggris · DOAJ Scopus

    Abstract Background The full range of cardiovascular complications related to the use of Immune checkpoint inhibitors (ICI) is not fully understood. We aim to describe the spectrum of cardiovascular adverse events (cvAEs) by presenting our real-world experience of the diagnosis and management of…

  13. Artikel Jurnal

    Long-term Real-world Survival Outcomes with Dual Immune Checkpoint Blockade in Synchronous Metastatic Renal Cell Carcinoma: Implications for the Design of Prospective Cytoreductive Nephrectomy Trials

    Leo Bickley; Elisabeth E. Fransen van de Putte; Luna van den Brink dkk.

    European Urology Open Science, Vol. 83 · 2026 · Inggris · DOAJ Scopus

    Background and objective: Patients with synchronous metastatic renal cell carcinoma (s-mRCC) increasingly undergo systemic therapy with their primary tumour in situ. We report long-term survival outcomes and deferred cytoreductive nephrectromy (dCN) rates in an unselected real-world s-mRCC cohort…

  14. Artikel Jurnal

    Interpretability of radiomics models is improved when using feature group selection strategies for predicting molecular and clinical targets in clear-cell renal cell carcinoma: insights from the TRACERx Renal study

    Matthew R. Orton; Evan Hann; Simon J. Doran dkk.

    Cancer Imaging, Vol. 23 No. 1 · 2023 · Inggris · DOAJ Scopus

    Abstract Background The aim of this work is to evaluate the performance of radiomics predictions for a range of molecular, genomic and clinical targets in patients with clear cell renal cell carcinoma (ccRCC) and demonstrate the impact of novel feature selection strategies and sub-segmentations on…

  15. Artikel Jurnal

    Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinoma

    Richard Culliford; Samuel E. D. Lawrence; Charlie Mills dkk.

    Nature Communications, Vol. 15 No. 1 · 2024 · Inggris · DOAJ Scopus

    Abstract Clear cell renal cell carcinoma (ccRCC) is the most common form of kidney cancer, but a comprehensive description of its genomic landscape is lacking. We report the whole genome sequencing of 778 ccRCC patients enrolled in the 100,000 Genomes Project, providing for a detailed description…

  16. Artikel Jurnal

    Escape from nonsense-mediated decay associates with anti-tumor immunogenicity

    Kevin Litchfield; James L. Reading; Emilia L. Lim dkk.

    Nature Communications, Vol. 11 No. 1 · 2020 · Inggris · DOAJ Scopus

    The transcripts generated by frameshifts and indels in cancer are frequently degraded by nonsense mediated decay. Here, the authors show that some of these transcripts can escape this degradation mechanism and their prevalence correlates with tumour response to immunotherapy.

  17. Artikel Jurnal

    Clinical outcomes of patients with corticosteroid refractory immune checkpoint inhibitor-induced enterocolitis treated with infliximab

    Hajir Ibraheim; Sophie Papa; Nick Powell dkk.

    Journal for ImmunoTherapy of Cancer, Vol. 9 No. 7 · 2021 · Inggris · DOAJ Scopus

    Introduction Immune checkpoint inhibitors (CPIs) have changed the treatment landscape for many cancers, but also cause severe inflammatory side effects including enterocolitis. CPI-induced enterocolitis is treated empirically with corticosteroids, and infliximab (IFX) is used in…